[1] A. Furuta, K. Ito, T. Fujita, S. Koike, A. Shimizu, and N. Matsunaga, “Hepatic Enhancement in Multiphasic Contrast-Enhanced MDCT: Comparison of High- and Low-Iodine-Concentration Contrast Medium in Same Patients with Chronic Liver Disease,” Am. J. Roentgenol., vol. 183, no. 1, pp. 157–162, Jul. 2004
[2] Y. Yamashita et al., “Abdominal Helical CT: Evaluation of Optimal Doses of Intravenous Contrast Material—A Prospective Randomized Study,” Radiology, vol. 216, no. 3, pp. 718–723, Sep. 2000.
[3]Y. Tsuge et al., “Abdominal vascular and visceral parenchymal contrast enhancement in MDCT: Effects of injection duration,” Eur. J. Radiol., vol. 80, no. 2, pp. 259–264, 2011.
[4] K. T. Bae et al., “Aortic and Hepatic Contrast Enhancement with Abdominal 64-MDCT in Pediatric Patients: Effect of Body Weight and Iodine Dose,” Am. J. Roentgenol., vol. 191, no. 5, pp. 1589–1594, Nov. 2008.
[5] J. P. Heiken, J. A. Brink, B. L. McClennan, S. S. Sagel, T. M. Crowe, and M. V Gaines, “Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement,” Radiology, vol. 195, p. 353, 1995.
[6] A. Svensson et al., “Hepatic contrast medium enhancement at computed tomography and its correlation with various body size measures,” Acta radiol., vol. 53, no. 6, pp. 601–606, Jul. 2012.
[7] S.-T. Feng et al., “An Individually Optimized Protocol of Contrast Medium Injection in Enhanced CT Scan for Liver Imaging,” Contrast Media Mol. Imaging, vol. 2017, p. 7350429, Jul. 2017.
[8] K. T. Bae, “Intravenous Contrast Medium Administration and Scan Timing at CT: Considerations and Approaches,” Radiology, vol. 256, no. 1, pp. 32–61, Jul. 2010.